No head-to-head randomized controlled trial comparing Retatrutide vs Tirzepatide directly has been published as of 2026, making direct efficacy comparisons inferential based on cross-trial data
Three-month cost comparison: Branded Ozempic: $2,700-$3,600 Compounded semaglutide: $600-$1,200 Savings: $2,100-$2,400 Six-month cost comparison: Branded Ozempic: $5,400-$7,200 Compounded semaglutide: $1,200-$2,400 Savings: $4,200-$4,800 One-year cost comparison: Branded Ozempic: $10,800-$14,400 Compounded semaglutide: $2,400-$4,800 Savings: $8,400-$9,600 That year-long savings of $8,400-$9,600 is real money
Consult a Texas GLP-1 lawsuit lawyer to learn more
Moreover, recent studies suggest that ATTR-CM is significantly more prevalent than previously recognized
Several newer molecules are investigational and not FDA-approved as of 2026